Metoprolol Accord (Metoprolol Tartrate)

Metoprolol Tartrate selectively blocks β1‑adrenergic receptors in the heart, preventing catecholamines from increasing heart rate and contractility. This leads to a lower cardiac output, reduced renin release, and ultimately a decrease in systemic blood pressure and myocardial oxygen demand.

The specific dose of Metoprolol Accord is determined by the prescribing clinician based on the individual’s medical condition, response to therapy, and other factors such as renal function. Typical dosing ranges for the various indications exist, but the exact regimen should be set by a qualified healthcare professional.

The pregnancy category for Metoprolol Tartrate is not definitively established. It should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. Caution is also advised while breastfeeding, as the drug can be excreted in breast milk; a healthcare provider should evaluate the risk‑benefit balance.

To place an order, submit an enquiry on the Metoprolol Accord product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, and will request verification of trade or institutional credentials. The sales team then provides pricing, availability, shipping details and any necessary import documentation.

Metoprolol is a cardioselective β1‑blocker, offering a lower risk of bronchospasm compared with non‑selective agents like propranolol. Compared with atenolol, Metoprolol has a shorter half‑life and may require more frequent dosing, but both share similar efficacy for hypertension and angina. Choice of agent depends on patient comorbidities, dosing convenience and physician preference.

Metoprolol Accord should be stored at ambient temperature, below 25 °C, in its original packaging to protect it from moisture and light. Keep the product out of reach of children and avoid storing it in areas with high humidity or extreme heat.

Metoprolol Accord is taken orally, usually with a glass of water. It can be administered with or without food, but consistency with meals may help reduce gastrointestinal upset. Tablets should be swallowed whole and not crushed or chewed unless specifically instructed by a healthcare professional.

Serious adverse events include severe bradycardia, heart block, marked hypotension, bronchospasm in patients with reactive airway disease, and rare cases of cardiogenic shock. Patients should seek immediate medical attention if they experience fainting, extreme fatigue, difficulty breathing, or a rapid change in heart rhythm.

Metoprolol Accord is contraindicated in patients with known hypersensitivity to metoprolol or any component of the formulation, in those with severe bradycardia (heart rate < 45 bpm), second‑ or third‑degree atrioventricular block without a pacemaker, and in individuals with uncompensated heart failure or cardiogenic shock. Caution is also advised for patients with severe asthma or chronic obstructive pulmonary disease.